Patents by Inventor Jorgen VALEUR

Jorgen VALEUR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPANION DIAGNOSTIC METHOD FOR USE IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIETARY INTERVENTIONS OR FAECAL MICROBIOTA TRANSPLANT
    Publication number: 20220120747
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet. In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet, especially to determine the likelihood that the dietary intervention may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Application
    Filed: December 27, 2021
    Publication date: April 21, 2022
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
    Patent number: 11243203
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: February 8, 2022
    Assignee: GENETIC ANALYSIS AS
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Companion Diagnostic Method For Use In The Treatment of Irritable Bowel Syndrome With Dietary Interventions or Faecal Microbiota Transplant
    Publication number: 20200400666
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Application
    Filed: August 31, 2020
    Publication date: December 24, 2020
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant
    Patent number: 10794909
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Grant
    Filed: October 13, 2017
    Date of Patent: October 6, 2020
    Assignee: GENERIC ANALYSIS AS
    Inventors: Finn Terje Hegge, Christina Casen, Jorgen Valeur, Arne Roseth, Milada Cvancarova Smastuen
  • A Companion Diagnostic Method For Use In The Treatment of Irritable Bowel Syndrome With Dietary Interventions or Faecal Microbiota Transplant
    Publication number: 20200049708
    Abstract: The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet or faecal microbiota transplant (FMT). In particular, the method may be used to predict, or determine the likelihood of, a positive response of the subject with IBS to treatment with an IBS intervention diet or FMT, especially to determine the likelihood that the dietary intervention or FMT may have a positive (i.e. beneficial) effect on the subject's GI tract, specifically the GI tract microbiota, or other symptoms or complications of IBS (e.g. reducing severity thereof). The method of the present invention is based on analysing the abundance of certain bacteria in GI tract samples, e.g. by nucleic acid analysis.
    Type: Application
    Filed: October 13, 2017
    Publication date: February 13, 2020
    Inventors: Finn Terje HEGGE, Christina CASEN, Jorgen VALEUR, Arne ROSETH, Milada Cvancarova SMASTUEN